抗体-寡核酸合物在癌症治疗中:潜力和承诺
Qinghe Meng1, Mo Yang2, Fei Xing3
1Nanomedicine Center, The Great Bay Area National Institute for Nanotechnology Innovation, 136 Kaiyuan Avenue, Guangzhou, Guangdong 510700, China; School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, Guangdong 510006, China.
Critical reviews in oncology/hematology
|July 20, 2025
概括
抗体-寡核酸结合物 (AOCs) 通过使用基因调节寡核酸代替细胞毒药物来提供一种新的癌症治疗方法. 这种方法将重点从细胞杀死转移到基因调节,以改善向治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物结合化学 生物结合化学
背景情况:
- 抗体药物结合物 (ADC) 是一种先进的瘤治疗药物.
- ADCs使用向载体,链接器和细胞毒性有效载荷进行精确的治疗.
- 抗体-寡核酸合物 (AOCs) 代表了ADCs的演变.
研究的目的:
- 审查抗体-寡核酸合物 (AOC) 的生物学和化学.
- 检查AOC的设计组件,包括抗体,链接剂和寡核酸.
- 突出临床AOC候选人并评估癌症治疗中的挑战和机遇.
主要方法:
- 对抗体-寡核酸合物 (AOC) 的文献综述.
- 分析AOC设计原则:目标车辆,链接器和寡核酸有效载荷.
- 评估目前用于癌症治疗的临床AOC候选药物.
主要成果:
- AOCs用基因调节性寡核酸 (siRNA,ASO) 取代传统的细胞毒性有效载荷.
- 这将治疗策略从细胞杀死转变为基因调节.
- 一些有前途的AOC候选药物正在临床开发中,用于癌症治疗.
结论:
- 通过使基因调节成为可能,AOC为向癌症治疗提供了一个新的范式.
- 在AOC设计和结合化学方面的进步至关重要.
- AOC具有显著的潜力,可以彻底改变瘤治疗策略.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Hybridoma Technology
15.4K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.4K
Cancer Vaccines
516
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
516
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


